To celebrate International Women’s Day 2020, Bioanalysis Zone brought together a panel of experts to discuss issues surrounding gender parity in bioanalysis. This round-up summarizes our key take home messages from the expert panel.
Webinar live date: Thursday 23 March 2020 15:00 [GMT] 11:00 [EST] 08:00 [PST]. With ChipCytometry by Canopy Biosciences (MO, USA), you can phenotype each cell in your tissue sample individually, retaining morphology and spatial information.
Available on demand. Live date. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion focusing on new technologies. The panelists discuss how the bioanalytical field could learn from other industries and why we should be introducing new technologies.
Available on demand. Register for our exclusive Coffee Chat focusing on developments in cell and gene therapies. This informal discussion centers around gene therapy medicinal products and their potential to change the way we fight disease.
Available on demand. LC–MS based large molecule bioanalysis platform was developed, validated and applied for drug screening and preclinical pharmacokinetics.
Available on demand. The demonstration of similar immunogenicity is a critical requirement for the demonstration of similarity between a biosimilar candidate and the respective reference product.
Webinar now available on demand. The aim of DMPK is to enable scientists to learn the safety and efficacy of new molecular entities. HRMS is an important analytical tool used to study DMPK that continues to gain traction when quantifying molecules.
Webinar now available on demand. Absolute quantitation of intact biotherapeutics is enabled through advances in immunocapture techniques coupled to LC–MS.
Webinar live date: Thursday 12 December 2019 07:00 [PST] 10:00 [EST] 15:00 [GMT]. On December 12, join us as we discuss, with supporting case studies, how hybridization ELISA can be an effective approach to quantify antisense oligonucleotides in circulation and in their targeted tissue.
Scientists from Massachusetts Institute of Technology (MA, USA) have developed a urine test that can identify proteins associated with lung cancer. It is hoped the nanoparticle-based test could reduce the quantity of false positives and improve early detection.
Researchers from Mologic Ltd (Bedford, UK) have announced that they are currently validating a COVID-19 diagnostic test with the Liverpool School of Tropical Medicine (UK), St Georges’ University (London, UK).
To provide remote support for sites and patients enrolled in clinical trials, PRA Health Sciences (NC, USA) has expanded its mobile health platform. New capabilities could help to address sponsor needs for virtual support during the global COVID-19 pandemic.
We caught up with solid-phase microextraction pioneer Janusz Pawliszyn (University of Waterloo, ON, Canada) about what’s happened in the field since his review of coated blade spray published in Bioanalysis and what the future could hold for solid-phase microextraction-based techniques.